Expression of glial cell line‐derived neurotrophic factor in the brain and cerebrospinal fluid of the developing rat
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Expression of GDNF in developing rat brain from PND 1 to 14 and on PND 21 was examined immunocytochemically. At PND 1, intense diffuse immunoreactivity was noted within the cytoplasm of a diverse group of neuronal and nonneuronal cells, including choroid plexus epithelial cells, ependymal cells, tanycytes of the third ventricle, and cellular elements in the subarachnoid compartment. GDNF expression became more localized among these cells from PND 7–14 and was almost undetectable by PND 21. Although GDNF‐positive small glial cells were scattered within the cerebral cortical plate and the striatum already at PND 1, GDNF expression among astroglial cells within the corpus callosum and in the white matter adjacent to the lateral ventricles was more prominent between PND 5 and 8. GDNF expression among the pyramidal neurons of the cerebral cortex was evident relatively early in the postnatal period, but the neurons of the hippocampus and thalamus showed more intense immunoreactivity at later periods between PND 8–14. ELISA of the CSF revealed a rapid rise in GDNF levels from 71.4±10.9 pg/ml (mean±S.E.M.) at PND 1 to peak levels of 138.4±18.5, 135.1±5.4 and 132.9±8.0 pg/ml, at PND 5, 7 and 9, respectively. Peak CSF levels of GDNF occurred when GDNF expression was intense within astroglial cells in the corpus callosum and cerebral white matter. Thereafter, the levels gradually decreased to 76.5±9.7 pg/ml at PND 21. The widespread expression of GDNF among different cellular elements in the developing brain suggest that GDNF probably plays diverse functional roles in many different neuronal systems in addition to its known effects on the dopaminergic system. Developmental shifts in GDNF expression further suggest that GDNF may be of critical importance at different stages of brain growth and differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · cited 1×
“GDNF rescued dopaminergic neurons of the substantia nigra and noradrenergic neurons of locus coeruleus following lesions in adult rats, GDNF null mice showed apparently normal development of these neurons, suggesting that GDNF may not aect their development.(7,8,12,25) Nevertheless, the results of our study demonstra…”
ResultFunctional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955 · cited 1×
“Recent reports showing the protection of dopaminergic neurons from MPTPinduced injury or 6-OHDA toxicity and axotomy-induced degeneration support the notion that GDNF may be able to ameliorate neuronal degeneration in a number of neurodegenerative disorders, including dopaminergic neurons in Parkinson's disease.(4,5,1…”
BackgroundNeurturin, a relative of glial-cell-line-derived neurotrophic factor
Kotzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P., Creedon, D. J., Johnson Jr, E. M., & Milbrandt, J. (1996) · Nature · doi:10.1038/384467a0 · Cited by 710
Cited by
Vitamin d3 and brain development
Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J., & Feron, F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00040-x · Cited by 552
Hypothalamic tanycytes: a key component of brain-endocrine interaction
RODRIGUEZ, E., BLAZQUEZ, J., PASTOR, F., PELAEZ, B., PENA, P., PERUZZO, B., & AMAT, P. (2005) · International review of cytology · doi:10.1016/s0074-7696(05)47003-5 · Cited by 475
Ependymal cells: biology and pathology
Del Bigio, M. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0624-y · Cited by 386
Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin
Bespalov, M. M., Sidorova, Y. A., Tumova, S., Ahonen-Bishopp, A., Magalhães, A. C., Kulesskiy, E., Paveliev, M., Rivera, C., Rauvala, H., & Saarma, M. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009136 · Cited by 198
“…which was shown to be a ligand-induced cell adhesion molecule (Ledda et al., 2007) The possible involvement of syndecan-3 in GDNF signaling, supported by our in vitro data, could be highly relevant for migrating cells and growing axons (Golden et al., 1999; Ikeda et al., 1999; Koo and Choi, 2001).”
The Choroid Plexus in Healthy and Diseased Brain
Kaur, C., Rathnasamy, G., & Ling, E.-A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv030 · Cited by 176
“Apart from epithelial-cadherin that establishes adherent junctions, choroid plexus epithelium also expresses afadin (115), suggesting the existence of the nectin-afadin complex in the adherent junction formation (67).”
Background
Metadata
- Authors
- Ikeda, T., Xia, X. Y., Xia, Y. X., Ikenoue, T., & Choi, B. H.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 1999-09-07
- Volume
- 17
- Issue
- 7
- Pages
- 681-691
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W1969579226
- Cited by
- 39
- References
- 3
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of glial cell line‐derived neurotrophic factor in the brain and cerebrospinal fluid of the developing rat. https://app.cochat.ai/papers/10.1016/s0736-5748(99)00057-x
- The paper
- Ikeda, T., Xia, X. Y., Xia, Y. X., Ikenoue, T., & Choi, B. H. (1999). Expression of glial cell line‐derived neurotrophic factor in the brain and cerebrospinal fluid of the developing rat. International Journal of Developmental Neuroscience. https://doi.org/10.1016/s0736-5748(99)00057-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.